Effects of singlet oxygen generated by a broad-spectrum viral fusion inhibitor on membrane nanoarchitecture

Nanomedicine: Nanotechnology, Biology, and Medicine

Volumn 11, Issue 5, 2015, Pages 1163-1167

  Hollmann, Axel ^a   Gonçalves, Sónia ^a   Augusto, Marcelo T ^a   Castanho, Miguel A R B ^a   Lee, Benhur ^b   Santos, Nuno C ^a  

^a INSTITUTO DE MEDICINA MOLECULAR   (Portugal)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

AFM; Broad spectrum antiviral; Membrane organization; Singlet oxygen

Indexed keywords

ATOMIC FORCE MICROSCOPY; CELL MEMBRANES; MOLECULES; OXYGEN; PHOSPHOLIPIDS; VIRUSES;

BROAD SPECTRUM; MECHANISM OF ACTION; MEMBRANE BEHAVIOR; MEMBRANE REORGANIZATION; MEMBRANE THICKNESS; NANO-ARCHITECTURE; SINGLET OXYGEN; UNSATURATED PHOSPHOLIPIDS;

CYTOLOGY;

(1 PALMITOYL 2 OLEOYL GLYCERO 3 PHOSPHOCHOLINE); (1,2 PALMITOYL GLYCERO 3 PHOSPHOCHOLINE); PHOSPHOLIPID; REACTIVE OXYGEN METABOLITE; SINGLET OXYGEN; UNCLASSIFIED DRUG; VIRUS FUSION INHIBITOR; ANTIVIRUS AGENT; MEMBRANE LIPID; OXAZOLE DERIVATIVE; OXAZOLIDINE; THIOKETONE;

ARTICLE; ATOMIC FORCE MICROSCOPY; CELL MEMBRANE; CHEMICAL STRUCTURE; FLUORESCENCE SPECTROSCOPY; LIPID MEMBRANE; VIRUS ENVELOPE; CHEMISTRY; DRUG EFFECTS; METABOLISM; MOLECULAR MODEL; VIRUS ENTRY;

ANTIVIRAL AGENTS; CELL MEMBRANE; MEMBRANE LIPIDS; MICROSCOPY, ATOMIC FORCE; MODELS, MOLECULAR; OXAZOLES; PHOSPHOLIPIDS; SINGLET OXYGEN; THIONES; VIRUS INTERNALIZATION;

EID: 84931067341     PISSN: 15499634     EISSN: 15499642     Source Type: Journal    
DOI: 10.1016/j.nano.2015.02.014     Document Type: Article

References (20)

1. Wolf M.C., Freiberg A.N., Zhang T., Akyol-Ataman Z., Grock A., Hong P.W., et al. A broad-spectrum antiviral targeting entry of enveloped viruses. Proc Natl Acad Sci U S A 2010, 107:3157-3162.
2. Vigant F., Lee J., Hollmann A., Tanner L.B., Ataman Z.A., Yun T., et al. A mechanistic paradigm for broad-spectrum antivirals that target virus-cell fusion. PLos Pathog 2013, 9.
3. St Vincent M.R., Colpitts C.C., Ustinov A.V., Muqadas M., Joyce M.A., Barsby N.L., et al. Rigid amphipathic fusion inhibitors, small molecule antiviral compounds against enveloped viruses. Proc Natl Acad Sci U S A 2010, 107:17339-17344.
4. Vigant F., Hollmann A., Lee J., Santos N.C., Jung M.E., Lee B. The rigid amphipathic fusion inhibitor dUY11 acts through photosensitization of viruses. J Virol 2014, 88:1849-1853.
5. Hollmann A., Castanho M.A.R.B., Lee B., Santos N.C. Singlet oxygen effects on lipid membranes: implication on broad range viral fusion inhibitors mechanism of action. Biochem J 2014, 459:161-170.
6. Watabe N., Ishida Y., Ochiai A., Tokuoka Y., Kawashima N. Oxidation decomposition of unsaturated fatty acids by singlet oxygen in phospholipid bilayer membranes. J Oleo Sci 2007, 56:73-80.
7. Mayer L.D., Hope M.J., Cullis P.R. Vesicles of variable sizes produced by a rapid extrusion procedure. Biochim Biophys Acta 1986, 858:161-168.
8. Szoka F., Olson F., Heath T., Vail W., Mayhew E., Papahadjopoulos D. Preparation of unilamellar liposomes of intermediate size (0.1-0.2mumol) by a combination of reverse phase evaporation and extrusion through polycarbonate membranes. Biochim Biophys Acta 1980, 601:559-571.
9. Franquelim H.G., Gaspar D., Veiga A.S., Santos N.C., Castanho M.A.R.B. Decoding distinct membrane interactions of HIV-1 fusion inhibitors using a combined atomic force and fluorescence microscopy approach. Biochim Biophys Acta 1828, 2013:1777-1785.
10. Giocondi M.-C., Vié V., Lesniewska E., Milhiet P.-E., Zinke-Allmang M., Le Grimellec C. Phase topology and growth of single domains in lipid bilayers. Langmuir 2001, 17:1653-1659.
11. Zhao J., Wu J., Heberle F.A., Mills T.T., Klawitter P., Huang G., et al. Phase studies of model biomembranes: complex behavior of DSPC/DOPC/cholesterol. Biochim Biophys Acta 2007, 1768:2764-2776.
12. Stachowiak J.C., Brodsky F.M., Miller E.A. A cost-benefit analysis of the physical mechanisms of membrane curvature. Nat Cell Biol 2013, 15:1019-1027.
13. Lorizate M., Sachsenheimer T., Glass B., Habermann A., Gerl M.J., Krausslich H.G., et al. Comparative lipidomics analysis of HIV-1 particles and their producer cell membrane in different cell lines. Cell Microbiol 2013, 15:292-304.
14. Brugger B., Glass B., Haberkant P., Leibrecht I., Wieland F.T., Krausslich H.G. The HIV lipidome: a raft with an unusual composition. Proc Natl Acad Sci U S A 2006, 103:2641-2646.
15. Riske K.A., Sudbrack T.P., Archilha N.L., Uchoa A.F., Schroder A.P., Marques C.M., et al. Giant vesicles under oxidative stress induced by a membrane-anchored photosensitizer. Biophys J 2009, 97:1362-1370.
16. Weber G., Charitat T., Baptista M.S., Uchoa A.F., Pavani C., Junqueira H.C., et al. Lipid oxidation induces structural changes in biomimetic membranes. Soft Matter 2014, 10:4241-4247.
17. Franquelim H.G., Loura L.M., Santos N.C., Castanho M.A.R.B. Sifuvirtide screens rigid membrane surfaces. Establishment of a correlation between efficacy and membrane domain selectivity among HIV fusion inhibitor peptides. J Am Chem Soc 2008, 130:6215-6223.
18. Tirosh O., Kohen R., Katzhendler J., Alon A., Barenholz Y. Oxidative stress effect on the integrity of lipid bilayers is modulated by cholesterol level of bilayers. Chem Phys Lipids 1997, 87:17-22.
19. Mason R.P., Walter M.F., Mason P.E. Effect of oxidative stress on membrane structure: small-angle X-ray diffraction analysis. Free Radic Biol Med 1997, 23:419-425.
20. Chernomordik L.V., Kozlov M.M. Protein-lipid interplay in fusion and fission of biological membranes. Annu Rev Biochem 2003, 72:175-207.